Dr.Netra Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 26-07-2024
- Paid Up Capital ₹ 0.10 M
as on 26-07-2024
- Company Age 6 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Revenue %
(FY 2023)
- Profit 0.14%
(FY 2023)
- Ebitda
- Net Worth -16.95%
(FY 2023)
- Total Assets -46.23%
(FY 2023)
About Dr.Netra Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Sreenivasa Pallapu, Nikhil Sampangi, and Sreenivasa Pallapu serve as directors at the Company.
- CIN/LLPIN
U24100TG2018PTC126749
- Company No.
126749
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
18 Sep 2018
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dr.Netra Pharmaceuticals?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sreenivasa Pallapu  | Director | 18-Sep-2018 | Current |
| Nikhil Sampangi | Director | Current | |
| Sreenivasa Pallapu | Additional Director | Current |
Financial Performance of Dr.Netra Pharmaceuticals.
Dr.Netra Pharmaceuticals Private Limited, for the financial year ended 2023, experienced no change in revenue, with a 0% increase. The company also saw a slight improvement in profitability, with a 0.14% increase in profit. The company's net worth observed a substantial decline by a decrease of 16.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
What is the Ownership and Shareholding Structure of Dr.Netra Pharmaceuticals?
In 2023, Dr.Netra Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Sreenethralaya Eye Hospital And Laser Centre Private LimitedActive 14 years 9 monthsSreenivasa Pallapu and Sreenivasa Pallapu are mutual person
Sherwyn Pharmaceuticals Private LimitedActive 6 years 10 monthsSreenivasa Pallapu is a mutual person
- Credible Health Care Private LimitedActive 9 years 12 days
Sreenivasa Pallapu and Nikhil Sampangi are mutual person
- Vision Eye Crafts Hyd Private LimitedActive 13 years 9 months
Sreenivasa Pallapu and Sreenivasa Pallapu are mutual person
- Nirmalanetra Healthcare Private LimitedActive 1 year 5 months
Sreenivasa Pallapu, Nikhil Sampangi and 1 more are mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Dr.Netra Pharmaceuticals?
Unlock and access historical data on people associated with Dr.Netra Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dr.Netra Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dr.Netra Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
